ANNIE TOMS: Open Payments
NPI 1316589674 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,615 in 52 payments from 19 companies in 2025. Trend: 2023 $1,456 · 2024 $1,264 · 2025 $1,615
Food & beverage: $1,451Education: $164
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $350 |
| Novartis Pharmaceuticals Corporation | 8 | $227 |
| Syndax Pharmaceuticals, Inc. | 5 | $160 |
| Incyte Corporation | 5 | $137 |
| SOBI, INC | 4 | $111 |
| GlaxoSmithKline, LLC. | 4 | $108 |
| Celgene Corporation | 3 | $94 |
| ABBVIE INC. | 3 | $92 |
| AstraZeneca Pharmaceuticals LP | 2 | $66 |
| PFIZER INC. | 1 | $33 |
Products named: SCEMBLIX, JAKAFI, Cresemba, Vonjo, OJJAARA, REBLOZYL, CALQUENCE, Xospata.
Industry payments across TX — which companies pay providers there.
